Abstract:Objective: To explore the roles of hippocampal N-ethylmaleicimide sensitive factors (NSF) in the central sensitization of irritable bowel syndrome (IBS) like rats. Methods:①IBS rats were established by neonatal maternal separation (NMS) during post-natal days 3-21 and each one was put in cubicles separately for 3 h daily. The control rats were treated like IBS rats except NMS. The visceral hypersensitivity was assessed by recording the responses of the external oblique abdominal muscle to 40 and 60mmHg colorectal distention (CRD) when the rats were adult (8 weeks). ②The levels of hippocampal NSF were detected by the method of Western blot. ③The effects of NSF on visceral hypersensitivity were examined by the electromyogram (EMG) after the bilateral intrahippocampal injections of pep2m (a NSF specific inhibitor). ④The expression of GluR2 (one of AMPARs subtype) were tested by Western blot after the hippocampal slices were perfused with pep2m for 60 minutes. Results:①The expressions of hippocampal NSF significantly increased in IBS rats compared with control rats. ②Bilateral intrahippocampal injections of pep2m dose-dependently attenuate the visceral hypersensitivity in IBS like rats. ③After the hippocampus slices were perfused with pep2m, the expression of GluR2 decreased significantly in IBS rats, but there were no obvious change in control rats. Conclusion:Hippocampal NSF could induce chronic functional visceral hypersensitivity by enhancing the functions of AMPARs-GluR2.